Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD

The Original Article was published on 08 June 2020

Correction to: Nature Metabolism https://doi.org/10.1038/s42255-020-0215-8, published online 8 June 2020.

In the version of this article initially published, author Eveline Baumgart-Vogt had affiliation number 15; the correct affiliation number is 14. The error has been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Norbert Weissmann.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Seimetz, M., Sommer, N., Bednorz, M. et al. Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD. Nat Metab 2, 648 (2020). https://doi.org/10.1038/s42255-020-0248-z

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing